Laurus Labs, an Indian pharmaceutical company, agreed to acquire a 72.55% stake in Richcore Life Sciences, a biotechnology company, for $33m. “This acquisition will also help Hyderabad-based Laurus in becoming a leader in biocatalysis, as Richcore brings significant expertise in enzyme development for pharmaceutical and other industrial applications,” Satyanarayana Chava, Lauras Labs Founder and CEO.